| P50 | author | Tomas Hökfelt | Q2440397 |
| | Trevor Sharp | Q55362894 |
| | Willim Staines | Q59555043 |
| P2093 | author name string | L Terenius | |
| | M Reid | |
| | M Herrera-Marschitz | |
| | U Ungerstedt | |
| | I Christensson-Nylander | |
| P2860 | cites work | Evidence for the participation of nigrotectal gamma-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat. | Q49054539 |
| | Synaptic connections of substance P-immunoreactive nerve terminals in the substantia nigra of the rat. A correlated light- and electron-microscopic study | Q49118840 |
| | Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of subsaance P in substantia nigra slices of the rat | Q51867609 |
| | Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. | Q53921572 |
| | A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra | Q59084083 |
| | Paradoxical GABA excitation of nigral dopaminergic cells: Indirect mediation through reticulata inhibitory neurons | Q66985123 |
| | Electrophysiological evidence for º-agonist activity of dynorphin in rat brain | Q70209746 |
| | Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration | Q72520486 |
| | Dynorphin-immunoreactive neurons in the central nervous system of the rat | Q72544934 |
| | Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites | Q72577410 |
| | Dynorphin reduces calcium-dependent action potential duration by decreasing voltage-dependent calcium conductance | Q72583083 |
| | Effects of intranigral application of dopamine and substance P on the in vivo release of newly synthesized [(3)H]-dopamine in the ipsilateral caudate nucleus of the cat | Q84234622 |
| | Differential sensitivity of presumed dopaminergic and non-dopaminergic neurones in rat substantia nigra to electrophoretically applied substance P | Q48954895 |
| | Dynorphin-(1-13), an extraordinarily potent opioid peptide | Q24561638 |
| | EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS | Q28201187 |
| | EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. | Q34540614 |
| | Organizational principles in the peripheral sympathetic nervous system: Subdivision by coexisting peptides (somatostatin-, avian pancreatic polypeptide-, and vasoactive intestinal polypeptide-like immunoreactive materials | Q36283493 |
| | Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization | Q36295234 |
| | Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide | Q36380726 |
| | Monosynaptic input from the nucleus accumbens--ventral striatum region to retrogradely labelled nigrostriatal neurones. | Q36657154 |
| | The striatum and substantia nigra: A commentary on their relationships | Q38075185 |
| | Self-inhibition by Dopaminergic Neurons | Q38160998 |
| | Release and metabolism of substance P in rat hypothalamus | Q39128595 |
| | Release of substance P from isolated nerve endings | Q39132834 |
| | Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat | Q39141017 |
| | Distribution of substance P-like immunoreactivity in the central nervous system of the rat—II. Light microscopic localization in relation to catecholamine-containing neurons | Q39229358 |
| | Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study | Q39281401 |
| | The nigrotectal projection: a biochemical and ultrastructural characterization | Q39500571 |
| | Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways | Q39545503 |
| | Effects of substance P injected into the substantia nigra | Q40065719 |
| | Neurotransmitters in the basal ganglia | Q40093769 |
| | The Striatonigral Substance P Pathway and Dopaminergic Mechanisms | Q40104933 |
| | Classification of opioid receptors | Q40134332 |
| | Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: A biochemical and immunohistochemical study | Q40931353 |
| | Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals | Q40983250 |
| | d -Amphetamine-Induced Inhibition of Central Dopaminergic Neurons: Mediation by a Striato-Nigral Feedback Pathway | Q41077144 |
| | Interactions between dopamine and gamma-aminobutyrate in the substantia nigra: implications for the striatonigral output hypothesis | Q41606226 |
| | Evidence for a GABAergic inhibitory nigrotectal pathway in the rat. | Q41632091 |
| | Bifunctional reagents as vapour- and liquid-phase fixatives for immunohistochemistry | Q42054535 |
| | Presence of substance P and GABA in separate striatonigral neurons | Q42084208 |
| | U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist | Q42241726 |
| | The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat. | Q42486375 |
| | The role of GABA in the substantia nigra | Q43562154 |
| | Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. | Q44128835 |
| | Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. | Q44185914 |
| | Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra | Q44212047 |
| | Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation | Q44310595 |
| | Substance K and substance P in the ventral tegmental area | Q44318493 |
| | Opioid peptide-like immunoreactivity localized in GABAErgic neurons of rat neostriatum and central amygdaloid nucleus | Q44331108 |
| | Distribution and characterization of opioid peptides derived from proenkephalin A in human and rat central nervous system | Q44331318 |
| | Analysis of opioid and non-opioid end products of pro-dynorphin in the substantia nigra of the rat. | Q44344027 |
| | Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum | Q44352107 |
| | Functional studies with the opioid peptide dynorphin: Acute effects of injections into the substantia nigra reticulata of naive rats | Q44352369 |
| | Projections of substance P containing neurons from neostriatum to substantia nigra. | Q44622081 |
| | Rotatory behavior in rats by intranigral application of substance P and an eledoisin fragment | Q44931430 |
| | Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies | Q45850638 |
| | Multiple tachykinin receptors in guinea pig brain. High densities of substance K (neurokinin A) binding sites in the substantia nigra | Q46796361 |
| | Neuromedin L: A novel mammalian tachykinin identified in porcine spinal cord | Q46848898 |
| | Substance P release from the rat substantia nigra | Q48168329 |
| | Behavioural depressant and antinociceptive properties of substance P in the mouse: Possible implication of brain monoamines | Q48203420 |
| | On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra | Q48256295 |
| | Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain | Q48320466 |
| | An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis | Q48326816 |
| | Substance P in the substantia nigra | Q48387516 |
| | Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor | Q48395090 |
| | The action of substance P on mesencephalic reticular and substantia nigral neurones of the rat | Q48402563 |
| | Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra | Q48434297 |
| | GABA axons in synaptic contact with dopamine neurons in the substantia nigra: double immunocytochemistry with biotin-peroxidase and protein A-colloidal gold | Q48435315 |
| | Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat is heterogeneously organized for rotational behaviour | Q48439876 |
| | Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections | Q48439884 |
| | Dynorphin peptides in human substantia nigra | Q48459934 |
| | Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates | Q48461093 |
| | Demonstration and distribution of kassinin-like material (substance K) in the rat central nervous system | Q48468728 |
| | Substance K excites dopaminergic and non-dopaminergic neurons in rat substantia nigra | Q48480241 |
| | Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra | Q48496839 |
| | The striatonigral projection and nigrotectal neurons in the rat. A correlated light and electron microscopic study demonstrating a monosynaptic striatal input to identified nigrotectal neurons using a combined degeneration and horseradish peroxidase | Q48498100 |
| | Regional distribution and in vivo release of tachykinin-like immunoreactivities in rat brain: evidence for regional differences in relative proportions of tachykinins | Q48519093 |
| | Measurement of substance P metabolites in rat CNS. | Q48519358 |
| | Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing | Q48532407 |
| | Sequence and significance of dopamine metabolism in the rat brain | Q48537953 |
| | Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. | Q48586330 |
| | Evidence that striatal efferents relate to different dopamine receptors | Q48590534 |
| | The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method | Q48595124 |
| | Actions of D-Ala2-D-Leu5-enkephalin and dynorphin A (1–17) on neocortical neurons | Q48597926 |
| | Effects of dynorphin A (1–17), dynorphin A (1–13) and D-ala2-D-leu5-enkephalin on the excitability of pyramidal cells in CA1 and CA2 of the rat hippocampus | Q48597936 |
| | Regional distribution of substance P, neurokinin α and neurokinin β in rat central nervous system | Q48599826 |
| | Inhibition of the turnover of the brain dopamine after treatment with the gammaaminobutyrate: 2-oxyglutarate transaminase inhibitor aminooxyacetic acid | Q48606003 |
| | Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis | Q48611939 |
| | Two distinct strio-nigral substance P pathways in the rat: An experimental immunohistochemical study | Q48634510 |
| | Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra | Q48637493 |
| | Regional distribution of kassinin-like immunoreactivity in rat central and peripheral tissues and the effect of capsaicin | Q48642846 |
| | Distribution of immunoreactive dynorphin A1-8 in discrete nuclei of the rat brain: comparison with dynorphin A. | Q48642924 |
| | Effect of intranigral injections of dynorphin, dynorphin fragments and α-neoendorphin on rotational behaviour in the rat | Q48645581 |
| | The autoradiographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain | Q48645772 |
| | Localization of immunoreactive enkephalins in GABA synthesizing neurons of the rat neostriatum | Q48668089 |
| | Distribution of immunoreactive dynorphin B in discrete areas of the rat brain and spinal cord | Q48668316 |
| | Distribution of immunoreactive beta-neo-endorphin in discrete areas of the rat brain and pituitary gland: comparison with alpha-neo-endorphin. | Q48672154 |
| | The distribution of immunoreactive alpha-neo-endorphin in the central nervous system of the rat. | Q48672161 |
| | In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. | Q48712656 |
| | Distribution of immunoreactive dynorphin in the central nervous system of the rat. | Q48713538 |
| | The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra | Q48722715 |
| | Nonopiate effects of dynorphin and des-Tyr-dynorphin | Q48860062 |
| | Comparison of the Distribution of Dynorphin Systems and Enkephalin Systems in Brain | Q48860073 |
| | Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway | Q48872243 |
| | Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. | Q48876521 |
| | Actions of substance P and opiates in the rat substantia nigra | Q48930623 |
| | The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system: an immunohistochemical study | Q48949801 |
| P433 | issue | 1 | |
| P921 | main subject | dynorphin | Q324076 |
| | substance P | Q411041 |
| P304 | page(s) | 193-207 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | Experimental Brain Research | Q13358841 |
| P1476 | title | Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis | |
| P478 | volume | 64 | |